SKAN Group AG (SKAN.SW)
CHF 74.5
(4.49%)
CHF 74.5
(4.49%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 50.14 Million CHF | 37.77% |
| 2022 | 40.15 Million CHF | 12.74% |
| 2021 | 32.38 Million CHF | 64.84% |
| 2020 | 16.48 Million CHF | 9.03% |
| 2019 | 18.12 Million CHF | 220.08% |
| 2018 | 6.07 Million CHF | -63.09% |
| 2017 | 19.09 Million CHF | -5.82% |
| 2016 | 16.14 Million CHF | -12.52% |
| 2015 | 18.45 Million CHF | 5407.24% |
| 2014 | -347.72 Thousand CHF | -114.71% |
| 2013 | 2.36 Million CHF | -33.32% |
| 2012 | 3.53 Million CHF | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 10.75 Million CHF | 0.0% |
| 2024 Q1 | 10.75 Million CHF | -65.91% |
| 2023 Q3 | 14.69 Million CHF | -20.99% |
| 2023 Q4 | 31.54 Million CHF | 114.74% |
| 2023 FY | - CHF | 37.77% |
| 2023 Q1 | 9.29 Million CHF | -68.46% |
| 2023 Q2 | 18.59 Million CHF | 100.0% |
| 2022 Q1 | 5.34 Million CHF | 242.53% |
| 2022 Q3 | 13.78 Million CHF | 863.03% |
| 2022 Q4 | 29.47 Million CHF | 113.87% |
| 2022 FY | - CHF | 12.74% |
| 2022 Q2 | 1.43 Million CHF | -73.2% |
| 2021 Q1 | 6.14 Million CHF | 21716.63% |
| 2021 FY | - CHF | 64.84% |
| 2021 Q2 | 1.76 Million CHF | -71.2% |
| 2021 Q3 | 8.48 Million CHF | 379.54% |
| 2021 Q4 | 1.55 Million CHF | -81.62% |
| 2020 Q4 | -28.41 Thousand CHF | -101.92% |
| 2020 FY | - CHF | 9.03% |
| 2020 Q1 | 6.89 Million CHF | -8.81% |
| 2020 Q2 | 28.41 Thousand CHF | -99.59% |
| 2020 Q3 | 1.47 Million CHF | 5095.17% |
| 2019 Q1 | 1.49 Million CHF | -4.72% |
| 2019 FY | - CHF | 220.08% |
| 2019 Q2 | 2.98 Million CHF | 99.49% |
| 2019 Q3 | 7.56 Million CHF | 153.15% |
| 2019 Q4 | 7.56 Million CHF | 0.0% |
| 2018 Q4 | 1.57 Million CHF | 0.0% |
| 2018 FY | - CHF | -63.09% |
| 2018 Q3 | 1.57 Million CHF | 7.18% |
| 2018 Q2 | 1.46 Million CHF | -0.0% |
| 2018 Q1 | 1.46 Million CHF | -72.0% |
| 2017 Q1 | 4.3 Million CHF | 66.39% |
| 2017 FY | - CHF | -5.82% |
| 2017 Q4 | 5.23 Million CHF | 0.0% |
| 2017 Q3 | 5.23 Million CHF | 21.64% |
| 2017 Q2 | 4.3 Million CHF | -0.0% |
| 2016 Q2 | 8.69 Million CHF | -0.0% |
| 2016 FY | - CHF | -12.52% |
| 2016 Q4 | 2.58 Million CHF | 0.02% |
| 2016 Q3 | 2.58 Million CHF | -70.25% |
| 2016 Q1 | 8.69 Million CHF | 470.89% |
| 2015 Q3 | 1.52 Million CHF | -83.73% |
| 2015 Q2 | 9.36 Million CHF | -0.0% |
| 2015 Q1 | 9.36 Million CHF | 5569.51% |
| 2015 FY | - CHF | 5407.24% |
| 2015 Q4 | 1.52 Million CHF | 0.0% |
| 2014 Q1 | -2653.00 CHF | -100.53% |
| 2014 Q2 | -2653.00 CHF | 0.0% |
| 2014 FY | - CHF | -114.71% |
| 2014 Q3 | -171.21 Thousand CHF | -6353.45% |
| 2014 Q4 | -171.21 Thousand CHF | 0.0% |
| 2013 Q3 | 499.01 Thousand CHF | -26.96% |
| 2013 Q2 | 683.24 Thousand CHF | 0.0% |
| 2013 FY | - CHF | -33.32% |
| 2013 Q4 | 499.01 Thousand CHF | 0.0% |
| 2013 Q1 | 683.24 Thousand CHF | -23.85% |
| 2012 Q3 | 897.2 Thousand CHF | 0.0% |
| 2012 FY | - CHF | 0.0% |
| 2012 Q4 | 897.2 Thousand CHF | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| COLTENE Holding AG | 23.8 Million CHF | -110.654% |
| Straumann Holding AG | 502.86 Million CHF | 90.028% |
| Tecan Group AG | 205.57 Million CHF | 75.608% |
| IVF Hartmann Holding AG | 23.36 Million CHF | -114.593% |
| Ypsomed Holding AG | 161.77 Million CHF | 69.004% |